tiprankstipranks
Trending News
More News >
Concord Biotech Ltd. (IN:CONCORDBIO)
:CONCORDBIO
India Market

Concord Biotech Ltd. (CONCORDBIO) Income Statement

Compare
1 Followers

Concord Biotech Ltd. Income Statement

Last quarter (Q1 2024), Concord Biotech Ltd.'s total revenue was ₹2.16B, an increase of 10.77% from the same quarter last year. In Q1, Concord Biotech Ltd.'s net income was ₹595.93M. See Concord Biotech Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
₹ 9.98B₹ 8.53B₹ 7.08B₹ 6.04B₹ 5.12B
Gross Profit
₹ 7.53B₹ 6.73B₹ 5.31B₹ 4.84B₹ 3.74B
Operating Expenses
₹ 1.46B₹ 3.84B₹ 2.94B₹ 1.80B₹ 1.60B
Depreciation and Amortization
₹ 535.91M₹ 540.32M₹ 500.50M₹ 275.23M₹ 200.53M
EBITDA
₹ 4.66B₹ 3.83B₹ 2.97B₹ 3.42B₹ 2.14B
Operating Income
₹ 6.26B₹ 3.27B₹ 2.44B₹ 3.07B₹ 1.94B
Other Income/Expenses
₹ -2.14B₹ -1.96B₹ -1.75B₹ 94.68M₹ -981.89M
Pretax Income
₹ 4.13B₹ 3.22B₹ 2.38B₹ 3.13B₹ 2.14B
Net Income
₹ 3.08B₹ 2.40B₹ 1.75B₹ 2.35B₹ 1.69B
Per Share Metrics
Basic EPS
₹ 29.45₹ 22.95₹ 16.72₹ 22.45₹ 16.16
Diluted EPS
₹ 29.45₹ 22.95₹ 16.72₹ 22.45₹ 16.16
Weighted Average Shares Outstanding
104.62M 104.62M 104.62M 104.62M 104.62M
Weighted Average Shares Outstanding (Diluted)
104.62M 104.62M 104.62M 104.62M 104.62M
Currency in INR

Concord Biotech Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis